RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash from operations

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥103.3B
P/E ratio
19.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 20253,506+126.34%
Mar 31, 20241,549-22.86%
Mar 31, 20232,008-68.36%
Mar 31, 20226,346+22.30%
Mar 31, 20215,189-32.95%
Mar 31, 20207,739+2176.18%
Mar 31, 2019340-96.75%
Mar 31, 201810,456-36.19%
Mar 31, 201716,386+47.13%
Mar 31, 201611,137+74.26%
Mar 31, 20156,391

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)